This article was originally published in The Gray Sheet
Acquires Angiomed, a Karlsruhe, Germany-based manufacturer of stents, catheters, guide and specialty wires, and biopsy products, for undisclosed terms. Bard says the acquisition will strengthen its position in Germany and Eastern Europe. About half of Angiomed's $40 mil. in 1993 revenues were generated in Germany. "We are excited about Angiomed's metal stent technology which is currently being marketed in urology, radiology, vascular surgery and gastroenterology in both Germany and France," Bard says, adding that "potential coronary applications are under development." Bard plans to consolidate its Munich-based German operation into Angiomed's headquarters in Karlsruhe, where Angiomed employs about 400 people. Some job reductions are anticipated
You may also be interested in...
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.
European Commission proposals for strengthening intellectual property protections in the EU, particularly the supplementary protection certificate (SPC) system, have been broadly welcomed by Europe’s brand industry. But the medical NGO, MSF, says the SPC proposals run counter to the commission’s own efforts to improve access to medicines.